摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpiperidinium bromide | 959671-67-1

中文名称
——
中文别名
——
英文名称
4-(2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpiperidinium bromide
英文别名
4-[(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethyl-piperidinium bromide;(1,1-Dimethylpiperidin-1-ium-4-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate;bromide
4-(2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpiperidinium bromide化学式
CAS
959671-67-1
化学式
Br*C20H30NO3
mdl
——
分子量
412.367
InChiKey
REBLMSBBTYZOPF-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.15
  • 重原子数:
    25
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.65
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为产物:
    参考文献:
    名称:
    Carry Over of Impurities: A Detailed Exemplification for Glycopyrrolate (NVA237)
    摘要:
    The original synthesis of glycopyrrolate (NVA237) was revised and shortened into an essentially one-pot process. Without isolating the intermediates, their purification became obsolete, thereby increasing the possibility of the carry over of impurities. For that reason, the actual, potential, and theoretical impurities of the starting materials cyclopentyl mandelic acid and 1-methyl-pyrrolidin-3-ol as well as byproducts which may occur during the synthesis were thoroughly investigated; furthermore, their transformation to possible impurities in the drug substance along the new synthetic route was performed to exclude them as actual impurities in the drug substance with certainty. The question is raised how detailed such investigation-which are fairly manageable for a simple product like glycopyrrolate-need to be.
    DOI:
    10.1021/op3001788
点击查看最新优质反应信息

文献信息

  • PROCESS FOR PREPARING QUATERNARY SALTS OF PIPERIDYL ESTERS OF MANDELIC ACID
    申请人:Job Andreas
    公开号:US20090270629A1
    公开(公告)日:2009-10-29
    What is described is a process for preparing compounds of the general formula (I) in which R 1 , R 2 and R 3 independently of one another represent hydrogen, an alkyl group or an aryl group, wherein compounds of the general formula (II) in which R 1 and R 2 have the meaning given for formula (I), are reacted with an alkylating agent of the general formula (III) R 3 X   (III) in which X represents a halogen atom and R 3 has the meaning given for formula (I), if appropriate in a solvent.
    所描述的是一种制备一般式(I)化合物的过程,其中R1、R2和R3分别表示氢、烷基或芳基,其中一般式(II)化合物中R1和R2具有公式(I)中给定的含义,与一般式(III)烷基化试剂反应,其中X代表卤素原子,R3具有公式(I)中给定的含义,如有必要在溶剂中进行。
  • NEW COSMETICS SOLVENTS COMPRISING ASCORBIC ACID
    申请人:Beiersdorf AG
    公开号:EP4011353A1
    公开(公告)日:2022-06-15
    The invention is an eutectic solvent formed from the mixture of ascorbic acid (vitamin C) in combination with Betaine and a third component selected from the group comprising Water, Ethanol, Glycerol, Diols and/or Triols with 6 or less than 6 C-atoms, especially 1,3 - Propanediol, Butylene Glycol and Hexanediol. The new inventive eutectic solvents allows an improved incorporation of active ingredients into cosmetic compositions.
    本发明是一种共晶溶剂,由抗坏血酸维生素 C)与甜菜碱的混合物以及选自乙醇甘油、二元醇和/或具有 6 个或少于 6 个 C 原子的三元醇(尤其是 1,3 - 丙二醇丁二醇己二醇)的第三种成分组成。新发明的共晶溶剂可以更好地将活性成分融入化妆品组合物中。
  • NEW COSMETICS SOLVENTS BASED ON TWO DIFFERENT COMPONENTS
    申请人:Beiersdorf AG
    公开号:EP4011354A1
    公开(公告)日:2022-06-15
    The invention is an eutectic solvent which is formed from the mixture of two different components selected from the group of sugars, aminoacids, short organic acids, polyols, betaines, quaternary ammonium salts in precise molar ratio. The new inventive eutectic solvents allow an improved incorporation of active ingredients into cosmetic compositions.
    本发明是一种共晶溶剂,由糖、氨基酸、短有机酸、多元醇、甜菜碱、季盐中的两种不同成分以精确的摩尔比混合而成。新发明的共晶溶剂可以更好地将活性成分融入化妆品组合物中。
  • NEW COSMETICS SOLVENTS BASED ON THREE DIFFERENT COMPONENTS
    申请人:Beiersdorf AG
    公开号:EP4011352A1
    公开(公告)日:2022-06-15
    The invention is an eutectic solvent which is formed from the mixture of three different components selected from the group consisting of Betaine, Glycerol, Urea, Citric Acid, Malic Acid, Glucose, Fructose, Sorbitol, Sucrose, Xylitol, Proline and Choline Chloride in precise molar ratio. The new inventive eutectic solvents allows an improved incorporation of active ingredients into cosmetic compositions.
    本发明是一种共晶溶剂,由选自甜菜碱甘油尿素柠檬酸苹果酸葡萄糖果糖山梨糖醇蔗糖木糖醇、脯酸和氯化胆碱的三种不同成分以精确的摩尔比混合而成。新发明的共晶溶剂可以更好地将活性成分融入化妆品成分中。
  • AROMATISCHE AMIDOTHIAZOLE, SIE ENTHALTENDE KOSMETISCHE ODER DERMATOLOGISCHE ZUBEREITUNGEN UND DEREN VERWENDUNG ZUR BEKÄMPFUNG UND PROPHYLAXE UNERWÜNSCHTER PIGMENTIERUNG DER HAUT
    申请人:Beiersdorf AG
    公开号:EP2758383B1
    公开(公告)日:2016-11-09
查看更多

同类化合物

(R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 ((3S,4R)-3-氨基-4-羟基哌啶-1-基)(2-(1-(环丙基甲基)-1H-吲哚-2-基)-7-甲氧基-1-甲基-1H-苯并[d]咪唑-5-基)甲酮盐酸盐 高氯酸哌啶 高托品酮肟 马来酸帕罗西汀 颜料红48:4 顺式3-氟哌啶-4-醇盐酸盐 顺式2,6-二甲基哌啶-4-酮 顺式1-苄基-4-甲基-3-甲氨基-哌啶 顺式-叔丁基4-羟基-3-甲基哌啶-1-羧酸酯 顺式-6-甲基-哌啶-1,3-二甲酸1-叔丁酯 顺式-5-(三氟甲基)哌啶-3-羧酸甲酯盐酸盐 顺式-4-叔丁基-2-甲基哌啶 顺式-4-Boc-氨基哌啶-3-甲酸甲酯 顺式-4-(氮杂环丁烷-1-基)-3-氟哌 顺式-3-顺式-4-氨基哌啶 顺式-3-甲氧基-4-氨基哌啶 顺式-3-BOC-3,7-二氮杂双环[4.2.0]辛烷 顺式-3-(1-吡咯烷基)环丁腈 顺式-3,5-哌啶二羧酸 顺式-3,4-二溴-3-甲基吡咯烷盐酸盐 顺式-2,6-二甲基-4-氧代哌啶-1-羧酸叔丁基酯 顺式-1-叔丁氧羰基-4-甲基氨基-3-羟基哌啶 顺式-1-boc-3,4-二氨基哌啶 顺式-1-(4-叔丁基环己基)-4-苯基-4-哌啶腈 顺式-1,3-二甲基-4-乙炔基-6-苯基-3,4-哌啶二醇 顺-4-(4-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-4-(2-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-3-氨基-4-氟哌啶-1-羧酸叔丁酯 顺-1-苄基-4-甲基哌啶-3-氨基酸甲酯盐酸盐 非莫西汀 雷芬那辛 雷拉地尔 阿维巴坦中间体4 阿格列汀杂质 阿尼利定盐酸盐 CII 阿尼利定 阿塔匹酮 阿哌沙班杂质BMS-591455 阿哌沙班杂质87 阿哌沙班杂质52 阿哌沙班杂质51 阿哌沙班杂质5 阿哌沙班杂质 阿哌沙班杂质 阿哌沙班-d3 阿哌沙班 阻聚剂701 间氨基谷氨酰胺